PROSTATE CANCER

Understand Prostate Cancer: Symptoms, Diagnosis, and  Treatment with Dr Dushyant Nadar – Doctor For Prostate Cancer Treatment in Noida

Prostate cancer is one of the most common types of cancer that affect men. It occurs when the cells in the prostate gland, a small walnut-shaped organ located below the bladder, start to grow uncontrollably. While prostate cancer is a serious disease, early detection and advanced treatment options have greatly improved the prognosis for those diagnosed with it.

Dr. Dushyant Nadar is a leading specialist in the field of urology, with a particular focus on prostate cancer treatment in Noida. With a wealth of experience and expertise, he offers patients the most advanced and personalized treatment options for prostate cancer. Dr. Nadar’s patient-centric approach and commitment to excellence make him a trusted choice for individuals seeking comprehensive care and support in their fight against prostate cancer.

Symptoms of Prostate Cancer:

In its early stages, prostate cancer often does not cause noticeable symptoms. However, as the disease progresses, some men may experience the following:

• Urinary Problems: Prostate cancer can press against the urethra, causing urinary difficulties such as a weak urine stream, frequent urination (especially at night), difficulty starting and stopping urination, and blood in the urine.
• Erectile Dysfunction: Difficulty achieving or maintaining an erection can be a symptom, though it is often related to other factors.
• Pain and Discomfort: Advanced prostate cancer may cause pain in the back, hips, or pelvis. Bone pain is also possible if the cancer has spread to the bones.

RISK FACTORS:

Several factors can increase a man’s risk of developing prostate cancer, including:

• Age: Prostate cancer is more common in older men, with the majority of cases diagnosed in men over 65.
• Family History: A family history of prostate cancer can increase your risk, particularly if your father, brother, or son has had the disease.
• Race/Ethnicity: African American men have a higher risk of developing prostate cancer than men of other racial or ethnic backgrounds.
• Diet: A diet high in red meat and low in fruits and vegetables may increase the risk.

DIAGNOSIS:

Prostate cancer is typically detected through a combination of screening tests and diagnostic procedures. Common methods of diagnosis include:

• Prostate-Specific Antigen (PSA) Test: This blood test measures the level of PSA, a protein produced by the prostate gland. Elevated PSA levels can indicate a potential problem, though further testing is needed for a definitive diagnosis.
• Digital Rectal Exam (DRE): During a DRE, a urologist inserts a gloved finger into the rectum to feel the prostate for abnormalities.
• Biopsy: If the PSA test and DRE suggest the possibility of cancer, a biopsy is performed. A small tissue sample is taken from the prostate gland and examined under a microscope to confirm the presence of cancer cells.

TREATMENT OPTIONS:

The choice of treatment for prostate cancer depends on various factors, including the stage and grade of the cancer, the patient’s age and overall health, and the patient’s preferences. Treatment options may include:

• Active Surveillance: For slow-growing, low-risk cancers, your urologist may recommend active surveillance, where regular monitoring is performed to ensure the cancer is not progressing.
• Surgery: Surgical removal of the prostate gland, known as a prostatectomy, is a common treatment option for localized prostate cancer.
• Radiation Therapy: High-energy rays are used to target and destroy cancer cells. This can be delivered externally or through internal radiation (brachytherapy).
• Hormone Therapy: This treatment aims to reduce the levels of male hormones (androgens) that fuel the growth of prostate cancer cells.
• Chemotherapy: In some cases, chemotherapy drugs may be used to treat advanced prostate cancer that has spread to other parts of the body.
• Immunotherapy: This treatment helps the immune system target and destroys cancer cells.